Angiotensin-(1-9) reverses experimental hypertension and cardiovascular damage by inhibition of the angiotensin converting enzyme/Ang II axis
Artículo

Open/ Download
Publication date
2014Metadata
Show full item record
Cómo citar
Ocaranza, Maria Paz
Cómo citar
Angiotensin-(1-9) reverses experimental hypertension and cardiovascular damage by inhibition of the angiotensin converting enzyme/Ang II axis
Author
- Ocaranza, Maria Paz;
- Moya, Jackeline;
- Barrientos, Victor;
- Alzamora, Rodrigo;
- Hevia, Daniel;
- Morales, Cristobal;
- Pinto, Melissa;
- Escudero, Nicolás;
- García Nannig, Lorena;
- Novoa, Ulises;
- Ayala, Pedro;
- Díaz Araya, Guillermo;
- Godoy, Ivan;
- Chiong Lay, Mario;
- Lavandero González, Sergio;
- Jalil Milad, Jorge;
Abstract
BACKGROUND:: Little is known about the biological effects of angiotensin-(1-9), but available evidence shows that angiotensin-(1-9) has beneficial effects in preventing/ameliorating cardiovascular remodeling. OBJECTIVE:: In this study, we evaluated whether angiotensin-(1-9) decreases hypertension and reverses experimental cardiovascular damage in the rat. METHODS AND RESULTS:: Angiotensin-(1-9) (600 ng/kg per min for 2 weeks) reduced already-established hypertension in rats with early high blood pressure induced by angiotensin II infusion or renal artery clipping. Angiotensin-(1-9) also improved cardiac (assessed by echocardiography) and endothelial function in small-diameter mesenteric arteries, cardiac and aortic wall hypertrophy, fibrosis, oxidative stress, collagen and transforming growth factor type β - 1 protein expression (assessed by western blot). The beneficial effect of angiotensin-(1-9) was blunted by coadministration of the angiotensin type 2(AT2) receptor blocker PD123319
Indexation
Artículo de publicación SCOPUS
Identifier
URI: https://repositorio.uchile.cl/handle/2250/158312
DOI: 10.1097/HJH.0000000000000094
ISSN: 14735598
02636352
Quote Item
Journal of Hypertension, Volumen 32, Issue 4, 2018, Pages 771-783
Collections
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 3.0 Chile
Related items
Showing items related by title, author, creator and subject.
-
Jalil Milad, Jorge; Piddo, Ana María; Cordova, Samuel; Chamorro, Gastón; Braun, Sandra; Jalil, Roberto; Vega, Jeanette; Jadue, Liliana; Lavandero González, Sergio; Lastra, Patricia (1999)The aim of this study was to estimate the prevalence of the different alleles of the angiotensin converting enzyme (ACE) gene insertion/deletion (I/D) polymorphism and associated plasma ACE activity, as well as cardiac ...
-
Johnson, M. C.; Vega Blanco, María Margarita; Vantman, D.; Troncoso, J. L.; Devoto, Luigi (1997)The role of angiotensin II (Angll) in ovarian steroidogenesis is not clearly understood. In order to study its action on progesterone synthesis and to determine which receptor subtype is involved, granulosa cells obtained ...
-
Aránguiz Urroz, Pablo Daniel; Soto Muñoz, Dagoberto; Contreras Ferrat, Ariel Eduardo; Troncoso Cotal, Rodrigo; Chiong Lay, Mario; Montenegro Obregón, José Joaquín; Venegas Pino, Daniel Esteban; Smolic Smolic, Christian; Ayala Jeria, Pedro Segundo; Thomas, W. G.; Lavandero González, Sergio; Díaz Araya, Guillermo (NATURE PUBLISHING GROUP, 2009-05)The Angiotensin II (Ang II) type 1 (AT(1)R) and type 2 (AT(2)R) receptors are increased in the heart following myocardial infarction and dilated cardiomyopathy, yet their contribution at a cellular level to compensation ...